Laser surgery in the womb could let moms with vasa previa deliver naturally
NCT ID NCT06290232
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at a fetal surgery called fetoscopic laser photocoagulation (FLP) to treat vasa previa, a condition where fetal blood vessels cover the womb opening, making vaginal delivery dangerous. The goal was to seal off these vessels to prevent bleeding and allow a safer delivery, possibly without a C-section. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant patient * Singleton pregnancy * Confirmed diagnosis of vasa previa, defined as unprotected fetal vessels running through the membranes at or within 5cm of the internal cervical os. Diagnosis must be confirmed after 26w0d, and before 32w5d * Able to undergo intervention during 30w0d to 32w6d * Type II vasa previa in which one placental lobe is considered to be accessory, defined as constituting less than 20% of the total placental mass seen on MRI and US imaging * Type II vasa previa in which multiple bridging vessels connect the two placental lobes (≥4 vessels), and only 1-2 vessel(s) run through or within 5cm of the internal cervical os * Patient is eligible to undergo anesthesia * Patient and biological father of the fetus (if available) are able to provide signed informed consent Exclusion Criteria: * Gestational age at referral higher than 32w6d * Multiple pregnancy * Vasa previa types I and III * Type II vasa previa in which the accessory lobe constitutes more than 20% of the total placental mass, as determined by the fetal surgeon during diagnostic fetoscopy * Type II vasa previa in which all of the bridging vessels between placental lobes are running over the internal cervical os * Fetal growth restriction, defined as estimated fetal weight or abdominal circumference less than the 10th percentile for gestational age * Abnormal fetal brain MRI, including delayed maturation, hemorrhage, arterial ischemic injury, abnormal ventricular size, or any congenital anomalies * Allergy or previous adverse reaction to ancillary medications with no available alternative * Preterm contractions and PPROM before surgery * Preeclampsia or uterine anomaly during the current pregnancy * Placenta previa, low-lying placenta, placenta accreta spectrum disorder * Suspicion of major recognized congenital syndrome on ultrasound or MRI that is not compatible with postnatal life * Maternal pre-pregnancy BMI \>40 * Active hepatitis B, hepatitis C, or HIV infection * High risk for congenital fetal bleeding disorders * Unreliable pregnancy dating due to an irregular menstrual cycle/uncertain last menstrual period with no confirmed dating from first trimester ultrasound * The surgeon determines that the procedure is not feasible for any other reason after diagnostic fetoscopy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for In utero procedure affecting fetus or newborn are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet and exercise in pregnancy shape a Child's health for years?
- Gut microbes in pregnancy and infancy: a window into lifelong health?
- Could more doula visits ease postpartum depression?
- Text messages and personal support may reduce pregnancy risks — a trial puts them to the test
- Ultrasound may predict hidden placental problems before delivery
- Can acupuncture and exercise ease pelvic pain during pregnancy?